Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
12,339,312
-
Share change
-
+2,402,098
-
Total reported value
-
$1,258,885,285
-
Put/Call ratio
-
183%
-
Price per share
-
$102.02
-
Number of holders
-
109
-
Value change
-
+$245,972,458
-
Number of buys
-
64
-
Number of sells
-
39
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q4 2014
As of 31 Dec 2014,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,339,312 shares.
The largest 10 holders included
FIRST TRUST ADVISORS LP, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, GOLDMAN SACHS GROUP INC, LPL Financial LLC, ROYAL BANK OF CANADA, and Ameriprise Financial Inc.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.